Sarah Haywood

Welcome – Sarah Haywood, CEO, MedCity

This month, I was pleased to be invited to speak as part of a panel at the quarterly Biotechs and the City event to talk about the role of crowdfunding in the healthcare and life sciences sector. Our Angel investment programme, Angels in MedCity, recently started collaborating with life sciences crowdfunding platform, Capital Cell, which offers a really exciting investment opportunity for SMEs, as an alternative route for fundraising. It was also fantastic to see in Beauhurst’s latest report, The Deal, that two of the top 5 crowdfunding deals in Q2 of this year were for life sciences companies in our region: Peptinnovate and Jupiter Diagnostics.

We also co-hosted an event with the National Institute for Health Research (NIHR) this month, looking at the challenges associated with undertaking clinical research in dementia. The workshop was set up to coincide with the Alzheimer’s Association International Conference 2017, the largest international meeting dedicated to advancing dementia science, which took place in London this month. It was great to get key industry and academic experts in a room to explore the issues and to showcase the enormous capability, resource and infrastructure that is available within the UK, through the NIHR, to support translational and clinical research in dementia. Finally, this month, we also ran a workshop with the British Standards Institution and DigitalHealth.London to address the lack of guidance for digital health SMEs in generating evidence to support the development and adoption of digital technologies. We will be sharing summaries and next steps from both events in our next update.

We are now looking forward to the next big events in our calendar – DigitalHealth.London’s one year anniversary event in September and our trip to Japan for BIO in October. We will share details about our activities in Yokohama in due course and we would love to catch up with anyone who is attending. There are also exciting new funding opportunities available through SBRI and Innovate UK, so please read on and continue to check on our website – – for more details.

Enjoy the summer!


Malcolm Lowe-Lauri

MedCity’s Spotlight on…UCLPartners

This month’s blog comes from Dr Charlie Davie, Managing Director at UCLPartners, as he discusses their work to reduce strokes among people with atrial fibrillation.

Read his blog here

£30m Advanced Therapies Centre for Guy’s and St Thomas’

King’s College London has been awarded £10m by HEFCE, to add to the £20m funding already raised, to establish an Advanced Therapies Centre aimed at developing cutting-edge experimental treatments for diseases such as cancer and diabetes.

Read more


Have Your Say!

The House of Lords Science and Technology Committee has launched an inquiry into Life Sciences and the Industrial Strategy.  It will investigate issues such as whether the Government has the right structures in place to support the sector; how the NHS can stimulate innovation; and whether a Life Sciences Minister should be appointed.

Find out more & contribute 

£70m drug discovery unit set for Sutton

The Institute for Cancer Research has received a £30k grant towards the cost of building a new, state-of-the-art drug discovery facility at their Sutton site. Once constructed it will form a key part of The London Cancer Hub, a new global hub for cancer research and treatment.

Read more 

Capital Cell

Digital Health Tech Catalyst

A new £35m 4-year programme that aims to speed up the development of new digital solutions for healthcare challenges opens for applications TODAY!

    Read more


Innovate UK needs you!

Are you a UK digital health expert? Would you like to assess funding applications for business-led innovation projects? Innovate UK’s Health and Life Sciences sector team is looking for assessors.

Read more 

Launched in April 2014, MedCity is a collaboration between the Mayor of London, Imperial College Academic Health Science Centre, King’s Health Partners, UCL Partners, Cambridge University Health Partners and Oxford Academic Health Science Centre. 

©2017 MedCity. All rights reserved.